Revvity Inc vs Ulta Beauty Inc — how do they compare? Revvity Inc trades at $154.72 (market cap $16.98B), while Ulta Beauty Inc trades at $569.26 (market cap $24.12B). The key difference: Ulta Beauty Inc is the larger of the two by market cap, and Revvity Inc pays a 0.18% dividend while Ulta Beauty Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revvity Inc for 12 Days and Ulta Beauty Inc for 92 Days on average.
| RVTY | ULTA | |
|---|---|---|
Market Cap | $16.98B | $24.12B |
Volume | 1,456,900 | 457,598 |
Sector | Health | Consumer Cyclical |
52-Week High | $157.36 | $706.82 |
52-Week Low | $82.26 | $450.75 |
Typical Hold Time | 12 Days | 92 Days |
Enterprise Value | $19.30B | $26.43B |
Dividend Yield | 0.18% | — |
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $155.01, up 0.92% with a bullish technical outlook. The stock shows strong earnings momentum with three consecutive quarterly beats and maintains solid profitability with 54.98% gross margins. Recent developments include new product launches in Europe and strategic acquisitions to expand metabolic disease research capabilities.
The investment case balances premium valuation (P/E 73.15) against consistent execution and growth initiatives. Key risks include China market pressures and margin compression, while analyst consensus remains positive with 52% buy ratings. Upside potential exists if Q3 earnings meet expectations in November.
ULTA Beauty trades at $570.02, up 4.5% today, showing strong momentum with a bullish technical setup and positive analyst sentiment. The company delivered Q2 2026 earnings beat ($6.55 actual vs. $6.22 expected) and raised 2026 guidance, supported by robust e-commerce growth. Valuation metrics show a P/E of 20.55 and P/S of 1.92, while profitability remains solid with 39.3% gross margins and 46.1% ROE. Recent news highlights expansion into wellness categories and omnichannel strength.
Outlook remains positive with consensus price target of $624.93 (9.6% upside), though margin pressure and flat store traffic pose execution risks. The stock's current price near resistance at $572 suggests potential near-term consolidation before further gains. Institutional ownership trends show mixed activity with recent CEO share sales offset by pension fund accumulation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →With more than 1,300 stores and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the U.S. The firm offers makeup (43% of 2021 sales), fragrances, skin care, and hair care products (20% of 2021 sales), and bath and body items. Ulta offers private-label products and merchandise from more than 500 vendors. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.
Read more on ULTA →